Frontiers in Genetics (Jun 2022)

Genomic, Proteomic, and Phenotypic Spectrum of Novel O-Sialoglycoprotein Endopeptidase Variant in Four Affected Individuals With Galloway-Mowat Syndrome

  • Malak Ali Alghamdi,
  • Malak Ali Alghamdi,
  • Hicham Benabdelkamel,
  • Afshan Masood,
  • Narjes Saheb Sharif-Askari,
  • Mahmood Y. Hachim,
  • Hamad Alsheikh,
  • Muddathir H. Hamad,
  • Mustafa A. Salih,
  • Fahad A. Bashiri,
  • Fahad A. Bashiri,
  • Khalid Alhasan,
  • Khalid Alhasan,
  • Khalid Alhasan,
  • Tarek Kashour,
  • Pilar Guatibonza Moreno,
  • Sabine Schröder,
  • Vasiliki Karageorgou,
  • Aida M. Bertoli-Avella,
  • Hisham Alkhalidi,
  • Dima Z. Jamjoom,
  • Ibrahim A. Alorainy,
  • Assim A. Alfadda,
  • Assim A. Alfadda,
  • Assim A. Alfadda,
  • Rabih Halwani

DOI
https://doi.org/10.3389/fgene.2022.806190
Journal volume & issue
Vol. 13

Abstract

Read online

Galloway-Mowat syndrome is a rare autosomal recessive disease characterized by a unique combination of renal and neurological manifestations, including early-onset steroid-resistant nephrotic syndrome, microcephaly, psychomotor delay, and gyral abnormalities of the brain. Most patients die during early childhood. Here, we identified a novel homozygous O-sialoglycoprotein endopeptidase (OSGEP) variant, NM_017807.3:c.973C>G (p.Arg325Gly), in four affected individuals in an extended consanguineous family from Saudi Arabia. We have described the detailed clinical characterization, brain imaging results, and muscle biopsy findings. The described phenotype varied from embryonic lethality to early pregnancy loss or death at the age of 9. Renal disease is often the cause of death. Protein modeling of this OSGEP variant confirmed its pathogenicity. In addition, proteomic analysis of the affected patients proposed a link between the KEOPS complex function and human pathology and suggested potential pathogenic mechanisms.

Keywords